nach oben

Erschienen in:

11.07.2018 | Magnetic Resonance

Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology

verfasst von: Stephanie Nougaret, Mariana Horta, Evis Sala, Yulia Lakhman, Isabelle Thomassin-Naggara, Aki Kido, Gabriele Masselli, Nishat Bharwani, Elizabeth Sadowski, Andrea Ertmer, Milagros Otero-Garcia, Rahel A. Kubik-Huch, Teresa M Cunha, Andrea Rockall, Rosemarie Forstner

Erschienen in: European Radiology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To update the 2009 ESUR endometrial cancer guidelines and propose strategies to standardize image acquisition, interpretation and reporting for endometrial cancer staging with MRI.

Methods

The published evidence-based data and the opinion of experts were combined using the RAND-UCLA Appropriateness Method and formed the basis for these consensus guidelines. The responses of the experts to 81 questions regarding the details of patient preparation, MR imaging protocol, image interpretation and reporting were collected, analysed and classified as “RECOMMENDED” versus “NOT RECOMMENDED” (if at least 80% consensus among experts) or uncertain (if less than 80% consensus among experts).

Results

Consensus regarding patient preparation, MR image acquisition, interpretation and reporting was determined using the RAND-UCLA Appropriateness Method. A tailored MR imaging protocol and a standardized report were recommended.

Conclusions

These consensus recommendations should be used as a guide for endometrial cancer staging with MRI.

Key points

• MRI is recommended for initial staging of endometrial cancer.

• MR imaging protocol should be tailored based on the risk of lymph node metastases.

• Myometrial invasion is best assessed using combined axial-oblique T2WI, DWI and contrast-enhanced imaging.

• The mnemonic “Clinical and MRI Critical TEAM” summarizes key elements of the standardized report.

Nur mit Berechtigung zugänglich

Kinkel K, Forstner R, Danza FM et al (2009) Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging. Eur Radiol 19:1565–1574PubMed

Colombo N, Preti E, Landoni F et al (2013) Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 Suppl 6:vi33-8

Colombo N, Creutzberg C, Amant F et al (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 26:2–30PubMed

Colombo N, Creutzberg C, Amant F et al (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol 27:16–41PubMed

Rossi EC, Kowalski LD, Scalici J et al (2017) A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 18:384–392PubMed

Frei KA, Kinkel K, Bonel HM, Lu Y, Zaloudek C, Hricak H (2000) Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a meta-analysis and Bayesian analysis. Radiology 216:444–449PubMed

Cunha TM, Felix A, Cabral I (2001) Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and gross visual inspection. Int J Gynecol Cancer 11:130–136PubMed

Bhosale P, Ma J, Iyer R et al (2016) Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging 43:316–324PubMed

Nougaret S, Reinhold C, Alsharif SS et al (2015) Endometrial cancer: combined MR volumetry and diffusion-weighted imaging for assessment of myometrial and lymphovascular invasion and tumor grade. Radiology 276:797–808PubMed

10.

Andreano A, Rechichi G, Rebora P, Sironi S, Valsecchi MG, Galimberti S (2014) MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis. Eur Radiol 24:1327–1338PubMed

11.

Seo JM, Kim CK, Choi D, Kwan Park B (2013) Endometrial cancer: utility of diffusion-weighted magnetic resonance imaging with background body signal suppression at 3T. J Magn Reson Imaging 37:1151–1159PubMed

12.

Hori M, Kim T, Onishi H et al (2013) Endometrial cancer: preoperative staging using three-dimensional T2-weighted turbo spin-echo and diffusion-weighted MR imaging at 3.0 T: a prospective comparative study. Eur Radiol 23:2296–2305PubMed

13.

Beddy P, Moyle P, Kataoka M et al (2012) Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 262:530–537PubMed

14.

Beets-Tan RG, Lambregts DM, Maas M et al (2013) Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 23:2522–2531PubMed

15.

Beets-Tan RGH, Lambregts DMJ, Maas M et al (2018) Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28:1465–1475PubMed

16.

Rockall AG, Meroni R, Sohaib SA et al (2007) Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 17:188–196PubMed

17.

Sala E, Crawford R, Senior E et al (2009) Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 19:141–146PubMed

18.

Takeuchi M, Matsuzaki K, Nishitani H (2009) Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion. Acta Radiol 50:947–953PubMed

19.

Emlik D, Kiresi D, Özdemir S, Çelik C, Karaköse S (2010) Preoperative assessment of myometrial and cervical invasion in endometrial carcinoma: comparison of multi-section dynamic MR imaging using a three dimensional FLASH technique and T2-weighted MR imaging. J Med Imaging Radiat Oncol 54:202–210PubMed

20.

Rechichi G, Galimberti S, Signorelli M, Perego P, Valsecchi MG, Sironi S (2010) Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T. Eur Radiol 20:754–762PubMed

21.

Dogan D, Inan N, Sarisoy HT et al (2013) Preoperative evaluation of myometrial invasion in endometrial carcinoma: diagnostic performance of 3T MRI. Abdom Imaging 38:388–396PubMed

22.

Koplay M, Dogan NU, Erdogan H et al (2014) Diagnostic efficacy of diffusion-weighted MRI for pre-operative assessment of myometrial and cervical invasion and pelvic lymph node metastasis in endometrial carcinoma. J Med Imaging Radiat Oncol 58:538–546 quiz 648PubMed

23.

Bonatti M, Stuefer J, Oberhofer N et al (2015) MRI for local staging of endometrial carcinoma: Is endovenous contrast medium administration still needed? Eur J Radiol 84:208–214PubMed

24.

Teng F, Zhang YF, Wang YM et al (2015) Contrast-enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis: diagnostic value and error analysis in endometrial carcinoma. Acta Obstet Gynecol Scand 94:266–273PubMed

25.

Du L, Li X, Qiu X, Liu X, Wang Y, Yu Y (2016) Application of FLASH-3D dynamic contrast-enhanced imaging for diagnosis of endometrial carcinoma. Br J Radiol 89:20160268PubMedPubMedCentral

26.

Lin G, Ng KK, Chang CJ et al (2009) Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging—initial experience. Radiology 250:784–792PubMed

27.

Wu LM, Xu JR, Gu HY, Hua J, Haacke EM, Hu J (2013) Predictive value of T2-weighted imaging and contrast-enhanced MR imaging in assessing myometrial invasion in endometrial cancer: a pooled analysis of prospective studies. Eur Radiol 23:435–449PubMed

28.

Park SB, Moon MH, Sung CK, Oh S, Lee YH (2014) Dynamic contrast-enhanced MR imaging of endometrial cancer: optimizing the imaging delay for tumour-myometrium contrast. Eur Radiol 24:2795–2799PubMed

29.

Manfredi R, Mirk P, Maresca G et al (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231:372–378PubMed

30.

Fujii S, Kido A, Baba T et al (2015) Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging. Eur J Radiol 84:581–589PubMed

31.

Sadowski EA, Robbins JB, Guite K et al (2015) Preoperative pelvic MRI and serum cancer antigen-125: selecting women with grade 1 endometrial cancer for lymphadenectomy. AJR Am J Roentgenol 205:W556–W564PubMed

32.

Shen SH, Chiou YY, Wang JH et al (2008) Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 190:481–488PubMed

33.

Rodriguez-Trujillo A, Martinez-Serrano MJ, Martinez-Roman S et al (2016) Preoperative assessment of myometrial invasion in endometrial cancer by 3D ultrasound and diffusion-weighted magnetic resonance imaging: a comparative study. Int J Gynecol Cancer 26:1105–1110PubMed

34.

Takeuchi M, Matsuzaki K, Harada M (2018) Evaluating myometrial invasion in endometrial cancer: comparison of reduced field-of-view diffusion-weighted imaging and dynamic contrast-enhanced MR imaging. Magn Reson Med Sci 17:28–34PubMed

35.

Sala E, Rockall A, Rangarajan D, Kubik-Huch RA (2010) The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Eur J Radiol 76:367–385PubMed

36.

Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125PubMedPubMedCentral

37.

Forstner R, Thomassin-Naggara I, Cunha TM et al (2017) ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol 27:2248–2257PubMed

38.

Deng L, Wang QP, Chen X, Duan XY, Wang W, Guo YM (2015) The combination of diffusion- and T2-weighted imaging in predicting deep myometrial invasion of endometrial cancer: a systematic review and meta-analysis. J Comput Assist Tomogr 39:661–673PubMed

39.

Horta M, Cunha T (2016) Endometrial cancer. In: Forstner R, Hamm B (eds) MRI and CT of the female pelvis. Berlin, Springer, p 1–30

40.

Nougaret S, Lakhman Y, Vargas HA et al (2017) From staging to prognostication: achievements and challenges of MR imaging in the assessment of endometrial cancer. Magn Reson Imaging Clin N Am 25:611–633PubMed

41.

Aalders JG, Thomas G (2007) Endometrial cancer—revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol 104:222–231PubMed

42.

Muallem MZ, Sehouli J, Almuheimid J, Richter R, Joukhadar R, Plett H (2016) Risk factors of lymph nodes metastases by endometrial cancer: a retrospective one-center study. Anticancer Res 36:4219–4225PubMed

43.

Haldorsen IS, Salvesen HB (2012) Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. Clin Radiol 67:2–12PubMed

44.

Thoeny HC, Froehlich JM, Triantafyllou M et al (2014) Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology 273:125–135PubMed

45.

Nougaret S, Tirumani SH, Addley H, Pandey H, Sala E, Reinhold C (2013) Pearls and pitfalls in MRI of gynecologic malignancy with diffusion-weighted technique. AJR Am J Roentgenol 200:261–276PubMed

46.

Inada Y, Matsuki M, Nakai G et al (2009) Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging? Eur J Radiol 70:122–127PubMed

47.

Roy C, Bierry G, Matau A, Bazille G, Pasquali R (2010) Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T. Eur Radiol 20:1803–1811PubMed

48.

Rechichi G, Galimberti S, Oriani M, Perego P, Valsecchi MG, Sironi S (2013) ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer. Eur Radiol 23:65–74PubMed

49.

Nakai G, Matsuki M, Inada Y et al (2008) Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr 32:764–768PubMed

50.

Boone JM, Mahesh M, Gingold EL, Seibert JA (2016) A call for the structured physicist report. J Am Coll Radiol 13:307–309PubMed

51.

Flusberg M, Ganeles J, Ekinci T et al (2017) Impact of a structured report template on the quality of CT and MRI reports for hepatocellular carcinoma diagnosis. J Am Coll Radiol 14:1206–1211PubMed

52.

Gassenmaier S, Armbruster M, Haasters F et al (2017) Structured reporting of MRI of the shoulder - improvement of report quality? Eur Radiol 27:4110–4119PubMed

53.

Sahni VA, Silveira PC, Sainani NI, Khorasani R (2015) Impact of a structured report template on the quality of MRI reports for rectal cancer staging. AJR Am J Roentgenol 205:584–588PubMed

54.

Samartine S, White L, McKeon D, Becker M (2015) Enhancing structured reporting: improving quality by tailoring the report to the clinical scenario. J Am Coll Radiol 12:845–847PubMed

55.

Kubik-Huch R, Weston M, Nougaret S et al (2018) European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas. Eur Radiol. https://doi.org/10.1007/s00330-017-5157-5

56.

Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E (2016) Endometrial cancer. Lancet 387:1094–1108PubMed

57.

Haoula Z, Salman M, Atiomo W (2012) Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 27:1327–1331PubMed

58.

Park JY, Seong SJ, Kim TJ, Kim JW, Bae DS, Nam JH (2017) Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer. Gynecol Oncol 146:39–43PubMed

59.

Yost KJ, Cheville AL, Al-Hilli MM et al (2014) Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obstet Gynecol 124:307–315PubMedPubMedCentral

60.

group As, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125-136

61.

Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375:1165–1172PubMed

62.

Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716PubMed

63.

Frost JA, Webster KE, Bryant A, Morrison J (2015) Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev CD007585. https://doi.org/ https://doi.org/10.1002/14651858.CD007585.pub3

64.

Imai K, Kato H, Katayama K et al (2016) A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy. Gynecol Oncol 142:273–277PubMed

65.

Holloway RW, Gupta S, Stavitzski NM et al (2016) Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. Gynecol Oncol 141:206–210PubMed

66.

Todo Y, Watari H, Kang S, Sakuragi N (2014) Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer. J Obstet Gynaecol Res 40:317–321PubMed

67.

Phelippeau J, Canlorbe G, Bendifallah S et al (2016) Preoperative diagnosis of tumor grade and type in endometrial cancer by pipelle sampling and hysteroscopy: results of a French study. Surg Oncol 25:370–377PubMed

68.

Batista TP, Cavalcanti CL, Tejo AA, Bezerra AL (2016) Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma. Eur J Surg Oncol 42:1367–1371PubMed

69.

Williams AR, Brechin S, Porter AJ, Warner P, Critchley HO (2008) Factors affecting adequacy of Pipelle and Tao Brush endometrial sampling. BJOG 115:1028–1036PubMed

70.

Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP (2000) The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 89:1765–1772PubMed

71.

Kishimoto K, Tajima S, Maeda I et al (2016) Endometrial cancer: correlation of apparent diffusion coefficient (ADC) with tumor cellularity and tumor grade. Acta Radiol 57:1021–1028PubMed

72.

Woo S, Cho JY, Kim SY, Kim SH (2014) Histogram analysis of apparent diffusion coefficient map of diffusion-weighted MRI in endometrial cancer: a preliminary correlation study with histological grade. Acta Radiol 55:1270–1277PubMed

73.

Rechichi G, Galimberti S, Signorelli M et al (2011) Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases. AJR Am J Roentgenol 197:256-62

74.

Bharwani N, Miquel ME, Sahdev A et al (2011) Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer. Br J Radiol 84:997–1004PubMedPubMedCentral

75.

Takahashi M, Kozawa E, Tanisaka M, Hasegawa K, Yasuda M, Sakai F (2016) Utility of histogram analysis of apparent diffusion coefficient maps obtained using 3.0T MRI for distinguishing uterine carcinosarcoma from endometrial carcinoma. J Magn Reson Imaging 43:1301–1307PubMed

76.

Mainenti PP, Pizzuti LM, Segreto S et al (2016) Diffusion volume (DV) measurement in endometrial and cervical cancer: a new MRI parameter in the evaluation of the tumor grading and the risk classification. Eur J Radiol 85:113–124PubMed

77.

Inoue C, Fujii S, Kaneda S et al (2014) Apparent diffusion coefficient (ADC) measurement in endometrial carcinoma: effect of region of interest methods on ADC values. J Magn Reson Imaging 40:157–161PubMed

78.

Fujii S, Matsusue E, Kigawa J et al (2008) Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 18:384–389PubMed

79.

Tamai K, Koyama T, Saga T et al (2007) Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 26:682–687PubMed

80.

Bakir VL, Bakir B, Sanli S et al (2017) Role of diffusion-weighted MRI in the differential diagnosis of endometrioid and non-endometrioid cancer of the uterus. Acta Radiol 58:758–767PubMed

81.

Husby JA, Salvesen OO, Magnussen IJ et al (2015) Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. Clin Radiol 70:487–494PubMed

82.

Kierans AS, Doshi AM, Dunst D, Popiolek D, Blank SV, Rosenkrantz AB (2016) Retrospective assessment of histogram-based diffusion metrics for differentiating benign and malignant endometrial lesions. J Comput Assist Tomogr 40:723–729PubMed

83.

Kilickesmez O, Bayramoglu S, Inci E, Cimilli T, Kayhan A (2009) Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones. Acta Radiol 50:340–347PubMed

84.

Nakamura K, Imafuku N, Nishida T et al (2012) Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer. Gynecol Oncol 124:335–339PubMed

85.

Wang J, Yu T, Bai R, Sun H, Zhao X, Li Y (2010) The value of the apparent diffusion coefficient in differentiating stage IA endometrial carcinoma from normal endometrium and benign diseases of the endometrium: initial study at 3-T magnetic resonance scanner. J Comput Assist Tomogr 34:332–337PubMed

86.

Bhosale P, Ramalingam P, Ma J et al (2017) Can reduced field-of-view diffusion sequence help assess microsatellite instability in FIGO stage 1 endometrial cancer? J Magn Reson Imaging 45:1216–1224PubMed

87.

Atri M, Zhang Z, Dehdashti F et al (2017) Utility of PET/CT to evaluate retroperitoneal lymph node metastasis in high-risk endometrial cancer: results of ACRIN 6671/GOG 0233 trial. Radiology 283:450–459PubMed

88.

Park JY, Lee JJ, Choi HJ et al (2017) The value of preoperative positron emission tomography/computed tomography in node-negative endometrial cancer on magnetic resonance imaging. Ann Surg Oncol 24:2303–2310PubMed

89.

Koh WJ, Abu-Rustum NR, Bean S, et al (2018) Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16:170–199

90.

Ueno Y, Forghani B, Forghani R et al (2017) Endometrial carcinoma: MR imaging-based texture model for preoperative risk stratification-a preliminary analysis. Radiology 284:748–757PubMed

91.

Todo Y, Watari H, Okamoto K et al (2013) Tumor volume successively reflects the state of disease progression in endometrial cancer. Gynecol Oncol 129:472–477PubMed

92.

MacKay HJ, Levine DA, Bae-Jump VL et al (2017) Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials. Oncotarget 8:84579–84594PubMedPubMedCentral

93.

Suhaimi SS, Ab Mutalib NS, Jamal R (2016) Understanding molecular landscape of endometrial cancer through next generation sequencing: what we have learned so far? Front Pharmacol 7:409PubMedPubMedCentral

94.

Werner HM, Salvesen HB (2014) Current status of molecular biomarkers in endometrial cancer. Curr Oncol Rep 16:403PubMed

95.

Tsikouras P, Bouchlariotou S, Vrachnis N et al (2013) Endometrial cancer: molecular and therapeutic aspects. Eur J Obstet Gynecol Reprod Biol 169:1–9PubMed

Titel: Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology
verfasst von: Stephanie Nougaret
Mariana Horta
Evis Sala
Yulia Lakhman
Isabelle Thomassin-Naggara
Aki Kido
Gabriele Masselli
Nishat Bharwani
Elizabeth Sadowski
Andrea Ertmer
Milagros Otero-Garcia
Rahel A. Kubik-Huch
Teresa M Cunha
Andrea Rockall
Rosemarie Forstner
Publikationsdatum: 11.07.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 2/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-018-5515-y

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology

Abstract

Objectives

Methods

Results

Conclusions

Key points

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Key points

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis

Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis

CAIPIRINHA-accelerated 10-min 3D TSE MRI of the ankle for the diagnosis of painful ankle conditions: Performance evaluation in 70 patients

Follow-up infarct volume as a mediator of endovascular treatment effect on functional outcome in ischaemic stroke

Obituary for Professor Alexander R. Margulis

Validation of scoring hip osteoarthritis with MRI (SHOMRI) scores using hip arthroscopy as a standard of reference

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie